Lacosamide
NDC 69367-352, Lacosamide, injection, from Westminster Pharmaceuticals, LLC.
- Product NDC
- 69367-352
- Status
- Listed
- Labeler
- Westminster Pharmaceuticals, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218706
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/69367-352 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69367-352-10 | 69367035210 | 10 VIAL, GLASS in 1 CARTON (69367-352-10) / 20 mL in 1 VIAL, GLASS (69367-352-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/61e3747a-3957-4840-81f0-313aefbd5d2b
Use it
Look up 69367-352 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69367-352 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69367-352. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.